Description

4-Piperidinecarboxamide,2,6-Dimethyl-,(2Alpha,4Alpha,6Alpha)-(9Ci) is a high-purity, stereochemically defined piperidine derivative of significant interest in advanced organic synthesis. This compound serves as a critical chiral building block and intermediate for the development of novel active pharmaceutical ingredients (APIs) and fine chemicals. It is primarily utilized by research institutions and pharmaceutical companies engaged in medicinal chemistry, process development, and the synthesis of complex molecules with specific stereochemical requirements.

Application

• Pharmaceutical Intermediate: A key chiral synthon in the research and development of new therapeutic agents, particularly in central nervous system (CNS) and cardiovascular drug candidates.
• Medicinal Chemistry Research: Used as a scaffold or precursor for constructing compound libraries in high-throughput screening and structure-activity relationship (SAR) studies.
• Asymmetric Synthesis: Employed as a chiral auxiliary or ligand precursor in catalytic asymmetric reactions to induce stereoselectivity.
• Fine Chemical Production: Serves as a building block for the synthesis of specialty chemicals, agrochemicals, and advanced materials requiring specific stereochemistry.
• Academic & Industrial R&D: A valuable reagent for investigating novel synthetic pathways and reaction mechanisms in organic chemistry laboratories.

Basic Information

Product Name	4-Piperidinecarboxamide,2,6-Dimethyl-,(2Alpha,4Alpha,6Alpha)-(9Ci)
CAS No.	179022-64-1
Molecular Formula	C8H16N2O
Molecular Weight	156.23 g/mol
Synonyms	(2α,4α,6α)-2,6-Dimethylpiperidine-4-carboxamide; 2,6-Dimethyl-4-piperidinecarboxamide (stereoisomer); 4-Carbamoyl-2,6-dimethylpiperidine; 2,6-Dimethylisonipecotamide; 179022-64-1; (2Alpha,4Alpha,6Alpha)-2,6-Dimethyl-4-piperidinecarboxamide; 4-Piperidinecarboxamide, 2,6-dimethyl-, (2α,4α,6α)-
EINECS	Contact for details

Quality Control

Our 4-Piperidinecarboxamide,2,6-Dimethyl-,(2Alpha,4Alpha,6Alpha)-(9Ci) is produced under strict quality management systems. Each batch undergoes comprehensive analytical testing, including chiral purity verification by HPLC, to ensure it meets the high standards required for pharmaceutical research and development. A detailed Certificate of Analysis (COA) providing specifications for identity, purity, and related substances is available for every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider storing under an inert atmosphere to maintain optimal stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Chiral Purity (Chiral HPLC)	≥ 99.0% ee
Related Substances (HPLC)	Total impurities ≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.